Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a “real-world” study
In conclusions, the bleeding rates are high in patients with acute PE who receive anticoagulant therapy. In addition to the already known bleeding risk factors, DM can also increase the bleeding risk significantly. Thus, good glycemic control may be essential after prescription of anticoagulant therapy.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Anemia | Bleeding | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Endocrinology | Hematology | Pulmonary Thromboembolism | Study | Thrombosis